Parenteral Drug Association
Connecting People, Science and Regulation ®
by: Oliver Stauffer, PTI
by: Amisha Patel
by: Michael Anyadiegwu, PhD, Renske Hesselink, PhD, and Ingrid Kromann
PDA
Oliver Stauffer, PTI
Londa Ritchey and Patrick Nieuwenhuizen, PharmaLex
Walter Morris, PDA
Justin Johnson and Walter Morris, PDA
Cristiana Campa, PhD, GSK and Sabrina Restrepo, PhD, Merck & Co.
Tony Cundell, PhD, Microbiological Consulting, LLC
Tejesh Marsale, PCI Pharma Services
Justin Johnson, PDA
Josh Russell, AST
Kent Malmros, Veeva Training Strategy and Iain Searle, Veeva Training Strategy
Emily Cheah, PhD, Charles River Laboratories-Singapore
Stephan Krause, PhD, Bristol Myers Squibb and Adam Boyer, Bristol Myers Squibb, Bristol Myers Squibb
Julian Petersen, groninger & co. gmbh and Richard Denk, SKAN AG
PDA, Inc.
Rebecca Brewer, Quality Executive Partners
Julian Petersen, groninger & co. gmbh
William Peterson, Merck
Toni Manzano, PhD, PDA Knowledge Management Roadmap Task Force
Ahmed Elsaid, Emergent Biosolution and Ajay Pazhayattil, PhD, cGMP World
Ron Branning, GXP Quality Systems, LLC, GXP Quality Systems, LLC
Hal Baseman, ValSource, Inc. and Gabriele Gori, MA, Independent Consultant
Noelle Clifford, PharmaLex, PharmaLex
Antonio Burazer, Takeda , Alexander Artau, Sanofi , Elisabeth Wagner, CSL Behring , and Joseph Straub, Merck
Simone Biel, PhD, Merck, Merck
Philippe Lauwers, Terumo Pharmaceutical Solutions
Zachary Beck, Eurofins
Jason Kerr, Moderna , Katie Bevard, Eli Lilly , and Maria Jacobs, PhD, Pfizer, Inc.
Walter Morris, PDA, Inc.
Renske ten Ham, PhD, UMC Utrecht and Richard Denk, SKAN AG
Maria Amaya, PhD, Genentech
Sebastian B. Teitz, PhD, Novo Nordisk
Anil Sawant, PhD
Roman Mathaes, PhD, Lonza
Qifeng Zhang, PhD, Lonza, Lonza Biologics
PDA Staff Author: David Jaworski, MBA
Ashutosh Anand, GSK
Mauro Giusti, PhD, Eli Lilly Italia, S.p.A
Andrea Sardella, National Research Council, Stevanato Group and Hanns-Christian Mahler, PhD, ten23 health
Manjula Aysola , Danielle DiTirro , Pamela Hamill , and Alison Armstrong, MIlliporeSigma
PDA Staff Author: Justin Johnson
Niravbhai Patel, PhD, and Dhavalkumar Surti, Nivagen Pharmaceuticals, Inc.
Alison Armstrong, PhD, Merck KGaA, Andy Bailey, ViruSure, Sean O’ Donnell, PhD, Eli Lily, and Sebastian Teitz, Biopharma Excellence
Petra Merker, PhD, Bayer AG, Tony Cundell, PhD, Microbiological Consulting, LLC, and Cynthia Martindale, Applied Rapid Microbiology Specialists, Ltd.
Patrick Nieuwenhuizen and Christopher Rogers, PharmaLex
James Agalloco, Agalloco & Association
Robin Smallwood, Veeva
Harolyn Clow, Teva Pharmaceuticals, and Don Singer, Ecolab Life Sciences
Chinmoy Roy, PDA
Vanessa Vasadi Figueroa, QxP and VVF Science, and Robert Ferer, QxP
Virginia Boldt, Accenture, Stephan Krause, PhD, Bristol Myers, and Friedrich von Wintzingerode, PhD, Roche-Genentech
Mary Howe, Bristol Myers Squibb, and Jason Kerr, Moderna
Patrick Costello, AbbVie Pharmaceuticals, and Vinny Browning, Amgen (Co-Chairs)
Izi Bruker, PhD, Kymanox, et al.
Denyse Baker, Eli Lilly and Company
Taras Tim Bredel, Injecto
Heike Merget-Millitzer, PhD, Janssen Inc.
Donald C. Singer, Ecolab, and Radha Tirumalai, PhD, Merck & Co., Inc.
Laura Brennan, Ecolab
Ajay Pazhayattil, PhD, cGMP World, Prasanna Sagar, PhD, Itaan Pharma, and Praveen Joseph, IPS-Integrated Project Services
Paula Peacos and Kim Sobien, ValSource, Inc.
By Maria Batalha, Rui Almeida, Ângela Martinho and Daniel Pais, PhD, Valgenesis
Patrick Nieuwenhuizen, PharmaLex
Ana Kuschel, PhD, West Pharmaceutical Services
Tamer Helmy, PhD
Kurt Jaecques, GSK, and Vineeta A. Pradhan, U.S. FDA
Cristiana Campa, PhD, GSK, and Elisabeth Vachette, Sartorius Stedim Biotech
David Jaworski, PDA, Inc.